课题基金 / 基金详情

Implementation and Commercialization of a Novel DNA Methylation-Based Diagnostic Tool

Implementation and Commercialization of a Novel DNA Methylation-Based Diagnostic Tool
新型 DNA 甲基化诊断工具的实施和商业化
批准号:
325196
负责人:
Weksberg Rosanna
金额:
$11.66万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2015
资助国家:
加拿大
项目状态:
已结题
起止时间:
2015-02-01 至 2016-02-01

项目摘要

项目成果

Weksberg Rosanna的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our proposal focuses on disorders caused by changes in epigenes, i.e.genes that control the expression of other genes, through the placement of functional epigenetic marks along the genetic code (DNA). These marks control whether genes are active or not.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determining the mechanisms underlying disease pathology in Kabuki syndrome
  • 批准号:
    445428
  • 项目类别:
    Operating Grants
  • 资助金额:
    $64.37万
  • 财政年份:
    2021
  • 负责人:
    Weksberg Rosanna
  • 依托单位:
Translating DNA methylation-based signatures into molecular diagnostics for human epigenomic disorders
  • 批准号:
    368113
  • 项目类别:
    Operating Grants
  • 资助金额:
    $43.42万
  • 财政年份:
    2017
  • 负责人:
    Weksberg Rosanna
  • 依托单位:
Genetic and Epigenetic Determinants of Syndromic Intellectual Disability
  • 批准号:
    267553
  • 项目类别:
    Operating Grants
  • 资助金额:
    $54.67万
  • 财政年份:
    2012
  • 负责人:
    Weksberg Rosanna
  • 依托单位:
海外基金